The following adverse events have been reported from clinical trial and post-marketing experience. (See Table.)
Frequencies are defined as: common (≥1/100, <1/10), uncommon (≥1/1,000, <1/100), rare (≥1/10,000, <1/1,000) and very rare (<1/10,000).
Click on icon to see table/diagram/image
There have been post-marketing reports of bone fractures (see Precautions).
View ADR Monitoring Form